XML 38 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Equity - USD ($)
Amount ($0.12 par)
Subscription Receivable
Additional Paid-in Capital
Legal Reserve
Warrants Reserves
Accumulated Other Comprehensive Income
Retained earnings (Deficit)
Non- controlling Interests
Total Equity
Balance at Dec. 31, 2020 $ 52,069 $ (50,000) $ 2,082,795 $ 223,500 $ 204,249 $ (4,722,294) $ 49,663 $ (2,160,018)
Balance (in Shares) at Dec. 31, 2020 [1] 433,677                
Currency translation adjustments (9,915) (9,915)
Stock-based compensation expense (Note 20) $ 563 (563)
Stock-based compensation expense (Note 20) (in Shares) [2] 4,689                
Remeasurements of defined benefit plan (Note 18) 627,193 627,193
Issuance of ordinary shares for acquisition of Handshake (Note 3) $ 131 327,632 327,763
Issuance of ordinary shares for acquisition of Handshake (Note 3) (in Shares) [2] 1,091                
Issuance of ordinary shares for acquisition of AI Singapore (Note 3) (12,719) (12,719)
Issuance of ordinary shares through initial public offering (“IPO”) (Note 19) $ 10,843 12,977,028 12,987,871
Issuance of ordinary shares through initial public offering (“IPO”) (Note 19) (in Shares) [2] 90,309                
Issuance of warrants through initial public offering (“IPO”) (Note 19) 5,422 251,036 256,458
Net loss for the year end from continuing operations (5,502,130) (29,224) (5,531,354)
Net loss (Profit) for the year end from discontinued operations 20,204 19,496 39,700
Balance at Dec. 31, 2021 $ 63,606 (50,000) 15,379,595 223,500 251,036 821,527 (10,204,220) 39,935 6,524,979
Balance (in Shares) at Dec. 31, 2021 [2] 529,766                
Currency translation adjustments (260,682) (260,682)
Stock-based compensation expense (Note 20) $ 840 251,255 252,095
Stock-based compensation expense (Note 20) (in Shares) [2] 7,000                
Cancellation of shares (Note 19)
Cancellation of shares (Note 19) (in Shares) [2] (2)                
Remeasurements of defined benefit plan (Note 18) 551,649 551,649
Issuance of ordinary shares through private placements (see Note 19) $ 49,978 18,225,750 18,275,728
Issuance of ordinary shares through private placements (see Note 19) (in Shares) [2] 416,483                
Issuance of ordinary shares through exercise of warrants $ 32,960 2,981,751 3,014,711
Issuance of ordinary shares through exercise of warrants (in Shares) [2] 274,659                
Issuance of ordinary shares for acquisition of subsidiaries $ 17,769 4,562,111 4,579,880
Issuance of ordinary shares for acquisition of subsidiaries (in Shares) [2] 148,071                
Issuance of ordinary shares for deposit paid for subsequently terminated acquisitions of subsidiaries subsequently terminated (see Note 19) $ 29,160 4,830,840 4,860,000
Issuance of ordinary shares for deposit paid for subsequently terminated acquisitions of subsidiaries subsequently terminated (see Note 19) (in Shares) [2] 243,000                
Net loss for the year end from continuing operations (18,549,500) (54,126) (18,603,626)
Net loss (Profit) for the year end from discontinued operations (15,294) (47,138) (62,432)
Balance at Dec. 31, 2022 $ 194,313 (50,000) 46,231,302 223,500 251,036 1,112,494 (28,769,014) (61,329) 19,132,302
Balance (in Shares) at Dec. 31, 2022 [2] 1,618,977                
Currency translation adjustments (130,860) (130,860)
Stock-based compensation expense (Note 20) 271,800 271,800
Cancellation of shares (Note 19) $ (29,441) (4,880,223) (4,909,664)
Cancellation of shares (Note 19) (in Shares) (245,339)                
Issuance of ordinary shares through CMPOs (Note 19) $ 593,542 20,273,844 20,867,386
Issuance of ordinary shares through CMPOs (Note 19) (in Shares) 4,946,184                
Remeasurements of defined benefit plan (Note 18) 3,486 3,486
Issuance of ordinary shares through exercise of warrants $ 15,468 491,224 506,692
Issuance of ordinary shares through exercise of warrants (in Shares) 128,901                
Issuance of ordinary shares for acquisition of assets (Note 19) $ 31,500 1,816,500 1,848,000
Issuance of ordinary shares for acquisition of assets (Note 19) (in Shares) 262,500                
Issuance of ordinary shares for a convertible note conversion (Note 15) $ 20,640 1,217,760 1,238,400
Issuance of ordinary shares for a convertible note conversion (Note 15) (in Shares) 172,000                
Issuance of ordinary shares for a borrowing conversion (Note 14) $ 353,658 15,560,957 15,914,615
Issuance of ordinary shares for a borrowing conversion (Note 14) (in Shares) 2,947,150                
Net loss for the year end from continuing operations (21,594,240) (29,280) (29,623,520)
Net loss (Profit) for the year end from discontinued operations 22,579 11,559 34,138
Balance at Dec. 31, 2023 $ 1,179,680 $ (50,000) $ 80,983,164 $ 223,500 $ 251,036 $ 985,120 $ (58,340,675) $ (79,050) $ 25,152,775
Balance (in Shares) at Dec. 31, 2023 9,830,373                
[1] Giving retroactive effect to the share consolidation on 2021 and 2023 August 20, 2021 and January 31, 2023, respectively, and the outstanding ordinary shares of a par value is automatically converted.
[2] Giving retroactive effect to the 2023 share consolidation on January 31, 2023, and the outstanding ordinary shares of a par value is automatically converted.